Shefner, Jeremy M.

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

Paganoni, S., Macklin, E. A., Hendrix, S., Berry, J. D., Elliott, M. A., Maiser, S., Karam, C., Caress, J. B., Owegi, M. A., Quick, A., et al. (2020) · New England Journal of Medicine

Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Cited by 536

Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Aggarwal, S. P., Zinman, L., Simpson, E., McKinley, J., Jackson, K. E., Pinto, H., Kaufman, P., Conwit, R. A., Schoenfeld, D., Shefner, J., et al. (2010) · The Lancet Neurology

Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Cited by 195

Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis

Paganoni, S., Hendrix, S., Dickson, S. P., Knowlton, N., Macklin, E. A., Berry, J. D., Elliott, M. A., Maiser, S., Karam, C., Caress, J. B., et al. (2021) · Muscle & Nerve

Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders Research

Cited by 180

Tolerance of high‐dose (3,000 mg/day) coenzyme Q10 in ALS

Ferrante, K. L., Shefner, J., Zhang, H., Betensky, R., O'Brien, M., Yu, H., Fantasia, M., Taft, J., Beal, M. F., Traynor, B., et al. (2005) · Neurology

Coenzyme Q10 studies and effectsAmyotrophic Lateral Sclerosis Research

Cited by 154

Lead Exposure as a Risk Factor for Amyotrophic Lateral Sclerosis

Kamel, F., Umbach, D. M., Hu, H., Munsat, T. L., Shefner, J. M., Taylor, J. A., & Sandler, D. P. (2005) · Neurodegenerative Diseases

Heavy Metal Exposure and ToxicityAmyotrophic Lateral Sclerosis Research

Cited by 125

Association of Cigarette Smoking with Amyotrophic Lateral Sclerosis

Kamel, F., Umbach, D. M., Munsat, T. L., Shefner, J. M., & Sandler, D. P. (1999) · Neuroepidemiology

Amyotrophic Lateral Sclerosis ResearchSmoking Behavior and Cessation

Cited by 100

Interim Safety Profile From the Feasibility Study of the BrainGate Neural Interface System

Rubin, D. B., Ajiboye, A. B., Barefoot, L., Bowker, M., Cash, S. S., Chen, D., Donoghue, J. P., Eskandar, E. N., Friehs, G., Grant, C., et al. (2023) · Neurology

Neuroscience and Neural EngineeringEEG and Brain-Computer Interfaces

Cited by 81

Amyotrophic lateral sclerosis care and research in the United States during the COVID ‐19 pandemic: Challenges and opportunities

Andrews, J. A., Berry, J. D., Baloh, R. H., Carberry, N., Cudkowicz, M. E., Dedi, B., Glass, J., Maragakis, N. J., Miller, T. M., Paganoni, S., et al. (2020) · Muscle & Nerve

Amyotrophic Lateral Sclerosis ResearchTelemedicine and Telehealth Implementation

Cited by 57

Repeatability of Commonly Used Speech and Language Features for Clinical Applications

Stegmann, G. M., Hahn, S., Liss, J., Shefner, J., Rutkove, S. B., Kawabata, K., Bhandari, S., Shelton, K., Duncan, C. J., & Berisha, V. (2020) · Digital Biomarkers

Voice and Speech DisordersEmotion and Mood Recognition

Cited by 47